Wolfe Research Initiates Coverage of Aflac (AFL) with Underperform Recommendation
Fintel15 days agoAFL

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Baidu, Ciena, CME Group, Dollar Tree, Dominion, Fabrinet, Honeywell Aerospace, Klarna, Pershing Square, and More
Markets turned south again Wednesday as surging yields and geopolitical fears rattled investors, but Wall Street analysts spotted opportunity and danger in names like Baidu, Klarna, Honeywell Aerospace, and Dollar Tree that traders need to see before the open.
Yahoo16 days agoAFL
Wolfe Research Initiates Coverage On Aflac with Underperform Rating, Announces Price Target of $103
Wolfe Research analyst Tracy Benguigui initiates coverage on Aflac (NYSE:AFL) with a Underperform rating and announces Price Target of $103.
Benzinga16 days agoAFL

Wells Fargo Maintains Equal-Weight on Aflac, Raises Price Target to $122
Wells Fargo analyst Wesley Carmichael maintains Aflac (NYSE:AFL) with a Equal-Weight and raises the price target from $120 to $122.
Benzinga16 days agoAFL

This Dividend Stock Has a Realistic Shot at Becoming a Dividend King
Aflac Incorporated (NYSE:AFL) has built an impressive dividend track record over the years. It has raised its dividend for 43 straight years, leaving the company just seven increases away from becoming a Dividend King, a milestone that requires 50 consecutive years of dividend growth. The company raised its quarterly dividend by 5.2% in early 2026 to […]
Yahoo16 days agoAFL
5 Revealing Analyst Questions From Aflac’s Q2 Earnings Call
Aflac’s second quarter results were met with a negative market reaction, as sales declined year-over-year despite meeting Wall Street’s expectations. Management attributed the drop in revenue largely to tough comparisons in Japan following last year’s launch of the Miraito cancer insurance product, as well as shifting consumer preferences. CEO Daniel Amos emphasized that, while sales in Japan were down this quarter, new offerings like Tsumitasu and Anshin Palette produced solid growth. In the U.
Yahoo20 days agoAFL

Trupanion: Profitable At Last, But Still Too Expensive To Buy (Upgrade)
SeekingAlpha21 days agoAFL
Aflac (AFL) Q2 2026 Earnings Call Transcript
Japan sales fell 5.6% as pretax margins expanded 230 basis points.
Yahoo21 days agoAFL

Zacks Industry Outlook Highlights Aflac, Globe Life, Trupanion and Employers Holdings
Accident and health insurers face medical-cost pressures, but stronger underwriting, technology adoption and demand for supplemental coverage support growth.
Yahoo23 days agoAFL

4 Accident & Health Insurers to Watch Amid Elevated Healthcare Costs
Accident and Health Insurance stocks like AFL, GL, TRUP and EIG are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.
Yahoo23 days agoAFL
AFL Q2 Deep Dive: Japan Product Refresh and U.S. Group Momentum Offset Sales Decline
Supplemental insurance provider Aflac (NYSE:AFL) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 6.9% year on year to $4.22 billion. Its non-GAAP profit of $1.75 per share was in line with analysts’ consensus estimates.
Yahoo24 days agoAFL

Aflac along with renowned educator Ron Clark and DonorsChoose embark on project to teach children social-emotional skills
As an extension of Aflac's long-term commitment to children and families facing cancer and blood disorders, the company today announced a new initiative to help U.S. educators teach students kindness and empathy through one of the most powerful tools available: reading. According to the International Journal on Studies in English Language and Literature (IJSELL), kindness can be explicitly and implicitly developed through sharing and discussing stories presented in children's literature.1
Yahoo24 days agoAFL

JP Morgan Maintains Neutral on Aflac, Lowers Price Target to $116
JP Morgan analyst Pablo Singzon maintains Aflac (NYSE:AFL) with a Neutral and lowers the price target from $117 to $116.
Benzinga24 days agoAFL

Keefe, Bruyette & Woods Maintains Market Perform on Aflac, Raises Price Target to $125
Keefe, Bruyette & Woods analyst Ryan Krueger maintains Aflac (NYSE:AFL) with a Market Perform and raises the price target from $120 to $125.
Benzinga24 days agoAFL
